Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYSCHEM (I). vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SYSCHEM (I).   MYLAN
EQUITY SHARE DATA
    SYSCHEM (I).
Mar-23
MYLAN
Dec-18
SYSCHEM (I)./
MYLAN
5-Yr Chart
Click to enlarge
High Rs653,967-   
Low Rs112,184-   
Sales per share (Unadj.) Rs30.31,825.4-  
Earnings per share (Unadj.) Rs1.449.6-  
Cash flow per share (Unadj.) Rs2.3391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs7.01,974.7-  
Shares outstanding (eoy) m31.89514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 74.7%   
Avg P/E ratio x27.062.0 43.5%  
P/CF ratio (eoy) x16.97.9 214.6%  
Price / Book Value ratio x5.51.6 350.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,2171,582,214 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m440-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m967939,158 0.1%  
Other income Rs m20-   
Total revenues Rs m970939,158 0.1%   
Gross profit Rs m86243,019 0.0%  
Depreciation Rs m27175,847 0.0%   
Interest Rs m045,170 0.0%   
Profit before tax Rs m6222,002 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m16-3,500 -0.5%   
Profit after tax Rs m4525,502 0.2%  
Gross profit margin %8.925.9 34.5%  
Effective tax rate %26.6-15.9 -167.3%   
Net profit margin %4.72.7 171.8%  
BALANCE SHEET DATA
Current assets Rs m586524,425 0.1%   
Current liabilities Rs m430382,364 0.1%   
Net working cap to sales %16.115.1 106.5%  
Current ratio x1.41.4 99.4%  
Inventory Days Days484 4.7%  
Debtors Days Days1,58293 1,695.9%  
Net fixed assets Rs m319182,181 0.2%   
Share capital Rs m319500 63.8%   
"Free" reserves Rs m-960-   
Net worth Rs m2231,015,998 0.0%   
Long term debt Rs m161,096,588 0.0%   
Total assets Rs m9042,725,301 0.0%  
Interest coverage x147.51.5 9,915.5%   
Debt to equity ratio x0.11.1 6.7%  
Sales to assets ratio x1.10.3 310.5%   
Return on assets %5.02.6 194.3%  
Return on equity %20.22.5 806.1%  
Return on capital %25.93.2 814.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-85195,157 -0.0%  
From Investments Rs m91-100,875 -0.1%  
From Financial Activity Rs mNA-90,916 0.0%  
Net Cashflow Rs m51,617 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SYSCHEM (I). With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SYSCHEM (I). With: SHREE GANESH REMEDIES   MERCURY LAB.  HIKAL.  PHAARMASIA  SUVEN LIFE SCIENCES  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.